Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Percentage of select orphan drug US sales by non/orphan use 2017

Percentage of select orphan drugs' U.S. revenues attributable to non-orphan usage in 2017

by Matej Mikulic, last edited Mar 7, 2019
Percentage of select orphan drug US sales by non/orphan use 2017 This statistic depicts the percentage of select orphan drugs' 2017 revenues in the U.S. by orphan or non-orphan use. According to the source, 88.7 percent of nivolumab (Opidivo) sales were for non-orphan uses.
Show more

Percentage of select orphan drugs' U.S. revenues attributable to non-orphan usage in 2017

Orphan indicationsNon-orphan indications
---
---
---
---
Orphan indicationsNon-orphan indications
---
---
---
---
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1.5m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $49 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1.5m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $49 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

Download Settings Share
Download started
Please be patient - this may take a moment
by Matej Mikulic, last edited Mar 7, 2019
This statistic depicts the percentage of select orphan drugs' 2017 revenues in the U.S. by orphan or non-orphan use. According to the source, 88.7 percent of nivolumab (Opidivo) sales were for non-orphan uses.
Show more
Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Related Studies: Available to Download in PDF or PPTX Format
Orphan drugs
Orphan drugs

All Information
in one Presentation

Orphan drugs

Everything On "Orphan drugs" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield

Marlene Greenfield
Vice President, Hearst Magazines

Statistics on "Orphan drugs"
  • Market overview
  • Companies
  • Products
The most important statistics
  • Research and development
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.